Table 1 Characteristics of Patients with Gallbladder Cancer in Shanghaia.

From: Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer

 

Clinical stage

P value

Early-stage (N = 32, %)

Late-stage (N = 102, %)

Survival (months)

  

<0.001b

  Median (interquartile range)

24.6 (9.3–47.8)

3.7 (1.6–7.7)

 

Age, years

  

0.754

  ≤54

4 (12.5)

9 (8.8)

 

  55–65

9 (28.1)

33 (32.4)

 

  ≥66

19 (59.4)

60 (58.8)

 

Sex

  

0.653

  Male

9 (28.1)

33 (32.3)

 

  Female

23 (71.9)

69 (67.7)

 

Education

  

0.749

  None/Primary

18 (56.2)

56 (54.9)

 

  Jr. Middle

7 (21.9)

26 (25.5)

 

  Sr. Middle

2 (6.3)

10 (9.8)

 

  Some college

5 (15.6)

10 (9.8)

 

Self-reported body mass index

  

0.683

  Underweight: < 18.5

2 (6.2)

9 (8.8)

 

  Normal: 18.5–24.9

15 (46.9)

55 (53.9)

 

  Overweight: 25–29.9

14 (43.8)

32 (31.4)

 

  Obese: ≥30.0

1 (3.1)

6 (5.9)

 

Regular Aspirin use (one year prior to interview)

  

0.328

  No

0 (0.0)

4 (4.0)

 

  Yes

32 (100.0)

97 (96.0)

 

  Missing

0

1

 

Ever smoker

  

0.124

  No

26 (81.3)

66 (65.4)

 

  Yes

6 (18.7)

35 (34.7)

 

  Missing

0

1

 

Ever drinker

  

0.791

  No

26 (81.2)

85 (83.3)

 

  Yes

6 (18.8)

17 (16.7)

 

Gallstone

  

0.454

  No

8 (25.0)

19 (18.6)

 

  Yes

24 (75.0)

83 (81.4)

 

Cholecystitis

  

0.667

  No

23 (71.9)

67 (65.7)

 

  Yes

9 (28.1)

35 (34.3)

 

Cholecystectomy

  

0.043

  No

8 (25.0)

46 (45.1)

 

  Yes

24 (75.0)

56 (54.9)

 
  1. aContinuous variables reported as median (interquartile range) and categorical variables reported as No. (%). bP value was determined using a log-rank test. Other P values were determined using a chi-square test or Fisher’s exact test (when the number of subjects in a cell was <5).